Recipient of federal assistance · DALLAS, TX

BERKSHIRE BIOMEDICAL CORPORATION

BERKSHIRE BIOMEDICAL CORPORATION received $0 in federal grants and other assistance in FY2026, on 2 actions, −100% vs FY2025. It has no federal contracts in the loaded years. Since FY2022: $2.5M.

Assistance · FY2026
$0
New awards
0
Actions
2
Since FY2022
$2.5M
UEI
F8XLTG96BCM9
Location
DALLAS, TX
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 266KFY2022
  2. 1.6MFY2023
  3. 371.5KFY2024
  4. 326.4KFY2025
  5. 0FY2026

Top programs · Awarding agencies

Obligations in FY2026.

Largest awards

  1. COPA, AN AUTOMATED MEDICATION DISPENSING AND REMOTE MANAGEMENT SYSTEM FOR AT HOME METHADONE DISPENSING - ABSTRACT METHADONE MAINTENANCE…$2.2M
    93.279 · Drug Use and Addiction Research Programs· National Institutes of Health· Project grant· Jul 19, 2022 – Jan 8, 2026· R44DA057185
  2. COPA: A CLINICAL PROGRAM TO EVALUATE BENEFITS OF A HAND-HELD, AUTOMATED, PERSONALIZED ORAL LIQUID DISPENSING SYSTEM FOR TAKE-HOME METHADONE…$326.4K
    93.279 · Drug Use and Addiction Research Programs· National Institutes of Health· Project grant· May 22, 2025 – Mar 9, 2026· R44DA061908

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2022–FY2026.